Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FHKR0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,317
Award facts
- Contract value 100% obligated
- $69,316.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,316.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 200 unit vials. The delivery order, effective through December 8, 2025, was issued without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and will serve as the sole contractor on this engagement with no identified subcontractor involvement.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical supply solutions, including branded and generic medications, biologics, and medical consumables to support military healthcare facilities worldwide. This delivery order exemplifies the operational deployment of the broader prime vendor framework to fulfill specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHKR0?
SPE2DR26FHKR0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FHKR0 worth?
The government has obligated $69,317 on SPE2DR26FHKR0.
Is contract SPE2DR26FHKR0 an order under another contract?
Yes. SPE2DR26FHKR0 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKR0 competed?
The extent of competition for SPE2DR26FHKR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award